Abstract:Objective Through the detection of chronic hepatitis B infection in different immune stages PBMC secretion of interferon gamma spot level,to discuss the immune pathogenesis of chronic hepatitis B and evaluate the treatment effect.Methods Using the density gradient centrifugation,separating the peripheral venous blood PMBC from a random selection of patients with chronic HBV infection (17 cases of atypical status group,14 cases of immune tolerance group and 16 cases of immune clearance group) and 15 cases of normal control group,using the HBsAg stimulus incubated with the test object PBMC cells,using ELISPOT detection the level of interferon gamma spot about chronic HBV infection,four groups of interferon gamma spot level were analysis of variance comparing.At the same time,on 17 cases of atypical status group (low level ALT)do liver biopsy,the liver specimens were graded inflammation and fibrosis index,analysis the association between interferon gamma spot level and liver inflammatory grading,9 cases chronic HBV infection of liver biopsy was higher or equal G2/S2 and received antiviral treatment again 3 months later using ELISPOT detection interferon gamma dot level.Results The comparison of interferon gamma spot number levels produced by PBMC which were stimulated in different immune stages of chronic hepatitis B infection.In addition to atypical status group and immune tolerance group,there was no significant difference,the remaining had significant difference,the immune clearance of chronic HBV infection HBsAg stimulus interferon gamma spot number level and serum ALT were significant correlated(r =0.976,P ＜0.05).Liver biopsy in 17 cases with low levels of ALT in chronic hepatitis B,liver tissue inflammation grade greater than or equal G2 total of 9 cases,accounting for 52.9％,at the same time its interferon gamma dot levels and liver inflammation grades had significant correlation (r =0.630,P =0.009).9 cases of chronic HBV infection which liver biopsy results greater than or equal G2/ S2 and received antiviral therapy before and after antiviral therapy interferon gamma spot number level had statistics difference (P =0.01).Conclusions Chronic hepatitis B with different immune stages the interferon gamma spot level expression is different,the immune clearance phase expression of the highest spot level.Low levels of ALT with chronic HBV infection the liver biopsy results prompt a large part of the patients achieved the antiviral indication,and the interferon gamma spot level and liver inflammation were positively correlated,prompting the inflammation of liver more obvious,the higher of the interferon gamma spot level.Detecting the interferon gamma spot level through ELISPOT can better evaluate the effect of antiviral treatment in patients with chronic hepatitis B infection.

Relationship of HBV replication with expression and secretion of IFN-γ in PBMC

[Relationship between the quantitative results of HBV DNA and HBV markers (HBV M) in population with low-level HBsAg].

Analysis on Clinical Features and Immunity in Chronic Hepatitis B Virus Infected Patients with Low-Level Hbsag

Identification of the Association Between HBcAg-specific T Cell and Viral Control in Chronic HBV Infection Using a Cultured ELISPOT Assay.

The Measurement of HBV DNA in peripheral blood mononuclear cells and its clinical applicability

HBsAg Levels in HBeAg-positive Chronic Hepatitis B Patients with Different Immune Conditions.

Changes of the peripheral Thelper cell cytokines of patients with chronic hepatitis B during antiviral treatment

Level Changes and Clinical Significance of Plasma IL-18,IP-10 in Patients with Chronic Hepatitis B During Antiviral Treatment

Expression profiles of circulating cytokines, chemokines and immune cells in patients with hepatitis B virus infection

Hepatitis B surface antigen levels during natural history of chronic hepatitis B: a Chinese perspective study.

Analysis of Hepatitis B Virus Intrahepatic Covalently Closed Circular DNA and Serum Viral Markers in Treatment-Naive Patients with Acute and Chronic HBV Infection.

Characterization of Microrna Expression Profiles Associated with Hepatitis B Virus Replication and Clearance in Vivo and in Vitro

Identification of phenotype and Interferon-alpha-producing capability of circulating type II dendritic cells and its clinical implication in HBV-infected patients]

Expression of type Ⅰ interferon in monocyte-derived dendritic cells after Toll like receptor 3 triggered in patients with chronic hepatitis B

HBsAg Inhibits IFN-α Production in Plasmacytoid Dendritic Cells Through TNF-α and IL-10 Induction in Monocytes.

Association of HBV Serological Markers with Host Antiviral Immune Response Relevant Hepatic Inflammatory Damage in Chronic HBV Infection.

Serum HBV DNA Plus RNA Shows Superiority in Reflecting the Activity of Intrahepatic Cccdna in Treatment-Naïve HBV-infected Individuals.

Quantitative Analyses of Intrahepatic HBV Cccdna and Serum HBsAg in 54 Patients with Chronic Hepatitis B

The frequency,phenotypes and invtiro cytotoxic effects of icrculating CD 56+T cells in the patients with chornic HCV infection

[Relationship Between the Quantities of Peripheral Dendritic Cells and of Serum HBV DNA and the Inflammatory Reaction Levels in the Liver].

Study on interferon gamma spot level of chronic hepatitis B infection in different immune stages and optimal opportunity of antiviral treatment in low levels of ALT patients